Altimmune logo.png
Altimmune to Participate at Two Upcoming Investor Conferences
May 29, 2024 07:31 ET | Altimmune, Inc
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will...
Result of auction of
Result of auction of mortgage covered bonds (SDRO’s) in series 11F, 12E and 12F
May 29, 2024 07:30 ET | Realkredit Danmark A/S
To Nasdaq Copenhagen A/S  Executive Management Bernstorffsgade 40 DK-1577 København V www.rd.dk Telephone +45 7012 5300 29 May 2024 Company announcement number 41/2024 Result of auction...
FTI_Logo_440x386.JPG
FTI Consulting Appoints Michael Spadea as North America Leader for Information Governance, Privacy and Security
May 29, 2024 07:30 ET | FTI Consulting, Inc.
WASHINGTON, May 29, 2024 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Michael Spadea as a Senior Managing Director and North America Leader of the...
FINAL _corected colors_else logo to use.png
Else Nutrition Adds New, Ready-to-Drink Kids Shakes at Canada’s Largest Grocery Chain
May 29, 2024 07:30 ET | Else Nutrition Holdings Inc.
Else Nutrition Adds New, Ready-to-Drink Kids Shakes at Canada’s Largest Grocery Chain
IRLABS - clients and partners logos (9).png
Stardust Power Announces Further Key Management Appointments
May 29, 2024 07:30 ET | Stardust Power Inc.
GREENWICH, Conn., May 29, 2024 (GLOBE NEWSWIRE) -- Stardust Power Inc. (“Stardust Power” or the “Company”), a development stage American manufacturer of battery-grade lithium products, today...
vyluma-logo-final.jpg
Vyluma Announces Marketing Authorization Application Validation for the European Union
May 29, 2024 07:30 ET | Vyluma, Inc.
Vyluma announces Marketing Authorisation Application (MAA) validation for the EU for NVK002 to slow the progression of pediatric myopia.
Altimmune logo.png
Altimmune to Present Clinical Data from Pemvidutide at Upcoming EASL International Liver Congress™ 2024
May 29, 2024 07:30 ET | Altimmune, Inc
GAITHERSBURG, Md., May 29, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that new data on the anti-inflammatory and...
logo.jpg
Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
May 29, 2024 07:30 ET | Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, May 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the Jefferies Global Healthcare Conference. Jeff Wade,...
STRM Logo 2024
Streamline Health® Announces New RevID™ Contract with 400-Bed Health System
May 29, 2024 07:30 ET | Streamline Health Solutions, Inc.
Atlanta, May 29, 2024 (GLOBE NEWSWIRE) -- – Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance,...
Arbutus Biopharma Logo
Arbutus to Participate in Jefferies Global Healthcare Conference
May 29, 2024 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...